2025-07-28
Post Time: 2025-07-28
Error: No content files found.Each year, 26,000 people in the UK develop wet age-related macular degeneration (wAMD). This is a condition in which blood vessels grow where they shouldn’t at the back of the eye. The result is which vitamins for eye health that your central vision slowly erodes in a fog of smoky greyness. Current creole pamplets on eye health treatment involves the injection of a drug directly into the eyeball once a month. Exonate, based in Cambridge and Nottingham, have a Seeding Drug Discovery Award from Wellcome’s Innovations team to optimise a new drug for wet AMD. Their drug targets a protein to switch off the growth of blood vessels in the eye, which should stop further sight loss. It will also be in the form of eye drops, avoiding all those injections. Exonate’s Chief Executive Catherine Beech arugula eye health and Chief Scientific Officer David Bates explain the science and its potential impact. This is just one great idea that Wellcome supports. For more, take a look at our playlist: 🔔 Subscribe to Wellcome on YouTube: 💬 SOCIAL MEDIA: Follow us on Twitter: Follow us on Instagram: Connect with us on LinkedIn: Find us on Facebook: 🔗 MORE FROM WELLCOME: Wellcome is a global charitable foundation. We want everyone to benefit from science’s potential to improve health and save lives. Read our latest stories, opinions and reports: Learn more about our work: Find our latest funding opportunities: